Home › Diabetes › NCT05734313

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults With Type 1 Diabetes

Who can join

Ages 18 to 64 · All sexes

Inclusion Criteria:

* Type 1 diabetes (T1D) duration ≥ 6 months
* 18-64 years old
* English- or Spanish-speaking
* Anxiety or depressive mood disorder as per structured diagnostic interview.

Exclusion Criteria:

* Developmental or sensory disability interfering with participation
* Current pregnancy
* Bipolar disorders, psychotic disorders, severe eating disorders, severe substance abuse disorders, or acute suicidal risk or self-harm
* Use of medications or recent medical procedures that would impact glycemic control or use of continuous glucose monitoring (CGM) over the study
* Received cognitive behavioral therapy (CBT) in last year or plans to initiate CBT; (6) temporary exclusion for recent initiation of psychotropic medication - must be on a stable dose for 6 weeks prior to enrollment.

About the study

This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.

What is being tested

• Unified protocol for cognitive behavioral therapy (UP-CBT) (behavioral)
• Continuous Glucose Monitoring (CGM) (device)

Sponsor: Albert Einstein College of Medicine · Participants: 94 · Started: Mar 31, 2023

Contact the study team

• Jeffrey Gonzalez, PhD · Phone: 646-592-4506
• Keyla Ordonez, BS · Phone: 631-747-9325

Official record on ClinicalTrials.gov — NCT05734313

Locations in the U.S.

Conditions

• Diabetes
• Type 1 Diabetes
• Depression
• Anxiety

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.